Add BrightSurf on Google Email

Mary Ann Liebert, Inc./Genetic Engineering News


Improving diagnosis of coronary artery disease in women -- recommendations of a national expert panel

The report highlights key diagnostic challenges in women, including atypical symptoms and the need to understand sex-specific differences underlying CAD. It emphasizes the importance of genomic approaches to diagnosis and the potential benefits of these new advances for improving accuracy and avoiding unnecessary invasive procedures.

SourceMary Ann Liebert, Inc./Genetic Engineering News·JournalPopulation Health Management·DateMar 2, 2015

Gene therapy pioneers Richard C. Mulligan and A. Dusty Miller reflect on their groundbreaking discovery

Pioneers in gene transfer technology, Drs. Mulligan and Miller developed the first DNA-based vectors to stably transfect cells with selectable markers. Their work laid the foundation for retroviral vector-based gene therapy strategies, leading to clinical testing and potential treatment of genetic diseases.

SourceMary Ann Liebert, Inc./Genetic Engineering News·JournalHuman Gene Therapy·DateFeb 5, 2015

Incidence of colorectal cancer increasing in young adults

A new study finds that colorectal cancer incidence is increasing among young adults aged 20-39 years in the US. The data also showed greater CRC risk for certain racial groups and differences in tumor location and stage at diagnosis compared to older adults. Colorectal cancer is uncommon in people younger than 50 years of age.

SourceMary Ann Liebert, Inc./Genetic Engineering News·JournalJournal of Adolescent and Young Adult Oncology·DateJan 22, 2015

The 'Berlin patient,' first and only person cured of HIV, speaks out

In a unique account, Timothy Ray Brown describes his experience as the first person cured of HIV through a stem cell transplant. He shares the details of the bold experiment that used a donor resistant to HIV infection. The 'Berlin patient' offers a rare glimpse into the human side of this groundbreaking treatment.

SourceMary Ann Liebert, Inc./Genetic Engineering News·JournalAIDS Research and Human Retroviruses·DateJan 6, 2015

How does enzymatic pretreatment affect the nanostructure and reaction space of lignocellulosic biomass?

A study reveals enzymatic hydrolysis and drying significantly alter lignocellulosic biomass nanostructure, reducing pore volume by up to 80%. The accessible reaction space is also reduced, hindering hydrolysis. This work sheds light on the importance of physical features in defining hydrolysis rates.

SourceMary Ann Liebert, Inc./Genetic Engineering News·JournalIndustrial Biotechnology·DateDec 18, 2014

Can a blood biomarker predict the presence of intracranial lesions following mild traumatic brain injury?

A new study suggests that measuring glial fibrillary acidic protein (GFAP) in the blood can predict the presence of intracranial lesions following mild traumatic brain injury. The study found GFAP to be a more reliable biomarker than S100β, which was not as effective in distinguishing between intracranial and extracranial lesions.

SourceMary Ann Liebert, Inc./Genetic Engineering News·JournalJournal of Neurotrauma·DateDec 11, 2014

New treatments for cancer, diabetes, and heart disease -- you may have a pig to thank

Researchers use genetically engineered pig models to study human diseases and identify new drug targets for cancer, cardiovascular diseases, diabetes, neurodegenerative diseases, ophthalmology, and xenotransplantation. These models enable the development of novel cell therapies to restore diseased tissues and organs.

SourceMary Ann Liebert, Inc./Genetic Engineering News·JournalBioResearch Open Access·DateNov 24, 2014

Expert recommendations for diagnosing pediatric acute onset neuropsychiatric syndrome

A consensus statement from leading clinicians and researchers recommends a systematic approach to evaluating youngsters with sudden onset of neuropsychiatric symptoms, including obsessive-compulsive disorder. The guidelines aim to clarify diagnostic boundaries, develop evaluation strategies, and identify urgently needed studies.

SourceMary Ann Liebert, Inc./Genetic Engineering News·JournalJournal of Child and Adolescent Psychopharmacology·DateOct 22, 2014

Interleukin-27: Can a cytokine with both pro & anti-inflammatory activity make a good drug target?

A new Review article explores the potential to target IL-27-activated mechanisms in diseases such as multiple sclerosis and Crohn's disease. The cytokine's dual anti-inflammatory and proinflammatory activities suggest it could be a significant determinant of inflammatory responses.

SourceMary Ann Liebert, Inc./Genetic Engineering News·JournalJournal of Interferon & Cytokine Research·DateOct 20, 2014

Pattern recognition receptors may be potent new drug targets for immune-mediated diseases

The article highlights the role of pattern recognition receptors in regulating immune responses and their potential as novel targets for developing potent new therapies. The JAK/STAT signaling network also plays a crucial role in disease pathogenesis, and targeting these networks may lead to improved treatments for various diseases.

SourceMary Ann Liebert, Inc./Genetic Engineering News·JournalJournal of Interferon & Cytokine Research·DateOct 15, 2014